Back to my company list

10X Genomics

The AI engine Fit Assessment

Beta

10x Genomics develops advanced DNA sequencing technology and innovative tools for analyzing biological systems, enabling researchers to uncover complex cellular interactions and gene expression patterns in various fields, including oncology and immunology. Their product portfolio includes instruments, consumables, and software designed to enhance scientific discovery.

Blurb

10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.

HQ Location

Pleasanton (United States)

Founded

2012

Employees

1001 - 5000

Total funding raised

$3.90B

Last Funding Event

Post-IPO Equity, January 1, 2020

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Genomic Data Analysis

10x Genomics is creating revolutionary DNA sequencing technology to help researchers better identify subtle variations that are overlooked by technologies that shred biological samples into tiny fragments before sequencing the short stretches and using computers to assembling them into a genome.